| 1 |
Li M, Du J, Liu W, Li Z, Lv F, Hu C, Dai Y, Zhang X, Zhang Z, Liu G, Pan Q, Yu Y, Wang X, Zhu P, Tan X, Garber PA, Zhou X. Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. ISME J 2023;17:549-60. [PMID: 36690780 DOI: 10.1038/s41396-023-01368-2] [Reference Citation Analysis]
|
| 2 |
Zhao L, Hall M, de Cesare M, MacIntyre-Cockett G, Lythgoe K, Fraser C, Bonsall D, Golubchik T, Ferretti L; COVID-19 Genomics UK (COG-UK) Consortium. The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA. Proc Biol Sci 2022;289:20221747. [PMID: 36382519 DOI: 10.1098/rspb.2022.1747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Bassett M, Salemi M, Rife Magalis B. Lessons Learned and Yet-to-Be Learned on the Importance of RNA Structure in SARS-CoV-2 Replication. Microbiol Mol Biol Rev. [DOI: 10.1128/mmbr.00057-21] [Reference Citation Analysis]
|
| 4 |
Hanna Campbell F. Trajectories of RNA Virus Mutation Hidden by Evolutionary Alternate Reality Thermodynamic Endpoints in Transformations in Response to Abiotic Habitat Stresses. Environmental Management - Pollution, Habitat, Ecology, and Sustainability 2022. [DOI: 10.5772/intechopen.100481] [Reference Citation Analysis]
|
| 5 |
Afrasiabi A, Alinejad-rokny H, Khosh A, Rahnama M, Lovell N, Xu Z, Ebrahimi D. The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06046-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Muñoz M, Patiño LH, Ballesteros N, Castañeda S, Luna N, Delgado L, Hernandez-Pereira C, Shaban MV, Muñoz SA, Paniz-Mondolfi A, Ramírez JD. Striking lineage diversity of severe acute respiratory syndrome coronavirus 2 from non-human sources. One Health 2022;14:100363. [PMID: 34931174 DOI: 10.1016/j.onehlt.2021.100363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, Chen XS. The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.. [DOI: 10.1101/2021.12.18.473309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Voloch CM, da Silva Francisco R Jr, de Almeida LGP, Brustolini OJ, Cardoso CC, Gerber AL, Guimarães APC, Leitão IC, Mariani D, Ota VA, Lima CX, Teixeira MM, Dias ACF, Galliez RM, Faffe DS, Pôrto LC, Aguiar RS, Castiñeira TMPP, Ferreira OC, Tanuri A, de Vasconcelos ATR. Intra-host evolution during SARS-CoV-2 prolonged infection. Virus Evol 2021;7:veab078. [PMID: 34642605 DOI: 10.1093/ve/veab078] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 9 |
Forni D, Cagliani R, Pontremoli C, Clerici M, Sironi M. The substitution spectra of coronavirus genomes. Brief Bioinform 2021:bbab382. [PMID: 34518866 DOI: 10.1093/bib/bbab382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 10 |
Rahman MM, Kader SB, Rizvi SMS. Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations. Heliyon 2021;7:e07866. [PMID: 34458642 DOI: 10.1016/j.heliyon.2021.e07866] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Sadykov M, Mourier T, Guan Q, Pain A. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction. J Mol Cell Biol 2021;13:225-7. [PMID: 33630074 DOI: 10.1093/jmcb/mjab011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Meshcheryakova A, Pietschmann P, Zimmermann P, Rogozin IB, Mechtcheriakova D. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19. Front Immunol 2021;12:690416. [PMID: 34276680 DOI: 10.3389/fimmu.2021.690416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
Fischer W, Giorgi EE, Chakraborty S, Nguyen K, Bhattacharya T, Theiler J, Goloboff PA, Yoon H, Abfalterer W, Foley BT, Tegally H, San JE, de Oliveira T, Gnanakaran S, Korber B; Network for Genomic Surveillance in South Africa (NGS-SA). HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens. Cell Host Microbe 2021;29:1093-110. [PMID: 34242582 DOI: 10.1016/j.chom.2021.05.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 14 |
Di Gioacchino A, Šulc P, Komarova AV, Greenbaum BD, Monasson R, Cocco S. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2. Mol Biol Evol 2021;38:2428-45. [PMID: 33555346 DOI: 10.1093/molbev/msab036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Anastassopoulou C, Manoussopoulos Y, Lampropoulou V, Tsakris A. Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes. Future Microbiol 2021;16:455-9. [PMID: 33960807 DOI: 10.2217/fmb-2020-0300] [Reference Citation Analysis]
|
| 16 |
Zhang M, Li L, Luo M, Liang B. Genomic characterization and evolution of SARS-CoV-2 of a Canadian population. PLoS One 2021;16:e0247799. [PMID: 33662015 DOI: 10.1371/journal.pone.0247799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Mourier T, Sadykov M, Carr MJ, Gonzalez G, Hall WW, Pain A. Host-directed editing of the SARS-CoV-2 genome. Biochem Biophys Res Commun 2021;538:35-9. [PMID: 33234239 DOI: 10.1016/j.bbrc.2020.10.092] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 18 |
Xia X. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design. Viruses 2021;13:109. [PMID: 33466921 DOI: 10.3390/v13010109] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 59.0] [Reference Citation Analysis]
|
| 19 |
Ullah A, Mabood N, Maqbool M, Khan L, Ullah M. Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target. Int J Med Sci 2021;18:3788-93. [PMID: 34790054 DOI: 10.7150/ijms.61779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
